These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6548427)

  • 21. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.
    Slovik DM; Rosenthal DI; Doppelt SH; Potts JT; Daly MA; Campbell JA; Neer RM
    J Bone Miner Res; 1986 Aug; 1(4):377-81. PubMed ID: 3503551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone increases bone formation and improves mineral balance in vitamin D-deficient female rats.
    Toromanoff A; Ammann P; Mosekilde L; Thomsen JS; Riond JL
    Endocrinology; 1997 Jun; 138(6):2449-57. PubMed ID: 9165035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism.
    Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT
    J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
    Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
    J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
    Law WM; Heath H
    J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans.
    Fraher LJ; Avram R; Watson PH; Hendy GN; Henderson JE; Chong KL; Goltzman D; Morley P; Willick GE; Whitfield JF; Hodsman AB
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2739-43. PubMed ID: 10443671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone increases circulating levels of fibronectin in vivo: modulating effect of ovariectomy.
    Sun BH; Mitnick M; Eielson C; Yao GQ; Paliwal I; Insogna K
    Endocrinology; 1997 Sep; 138(9):3918-24. PubMed ID: 9275082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTH-related peptide receptor.
    Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; D'Amour P
    Endocrinology; 2001 Apr; 142(4):1386-92. PubMed ID: 11250917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism.
    Hulter HN; Halloran BP; Toto RD; Peterson JC
    J Clin Invest; 1985 Aug; 76(2):695-702. PubMed ID: 3928683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic parathyroid hormone administration reverses the antihypertensive effect of calcium loading in young spontaneously hypertensive rats.
    Kishimoto H; Tsumura K; Fujioka S; Uchimoto S; Morii H
    Am J Hypertens; 1993 Mar; 6(3 Pt 1):234-40. PubMed ID: 8466711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
    Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
    J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
    Cosman F; Shen V; Herrington B; Lindsay R
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of conjugated estrogen on the calcitriol response to parathyroid hormone in postmenopausal women.
    Marcus R; Villa ML; Cheema M; Cheema C; Newhall K; Holloway L
    J Clin Endocrinol Metab; 1992 Feb; 74(2):413-8. PubMed ID: 1309837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study.
    Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H
    Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The turnover time of calcium in the exchangeable pools of bone in man and the long-term effect of a parathyroid hormone fragment.
    Reeve J
    Clin Endocrinol (Oxf); 1978 Jun; 8(6):445-55. PubMed ID: 668151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
    Reeve J; Arlot M; Price TR; Edouard C; Hesp R; Hulme P; Ashby JP; Zanelli JM; Green JR; Tellez M
    Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients.
    Lindsay R; Nieves J; Henneman E; Shen V; Cosman F
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1535-9. PubMed ID: 8263137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide.
    Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I
    Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal calcaemic response to PTH in the uraemic rat without secondary hyperparathyroidism.
    Berdud I; Martin-Malo A; Almaden Y; Tallon S; Concepcion MT; Torres A; Felsenfeld A; Aljama P; Rodriguez M
    Nephrol Dial Transplant; 1996 Jul; 11(7):1292-8. PubMed ID: 8672025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the dosing frequency of parathyroid hormone-(1-38) on its anabolic effect in bone and on the balance of calcium, phosphorus and magnesium.
    Riond JL; Goliat-von Fischer I; Küffer B; Toromanoff A; Forrer R
    Z Ernahrungswiss; 1998 Jun; 37(2):183-9. PubMed ID: 9698646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.